Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS: NWBO · Delayed Price · USD
0.460
-0.012 (-2.54%)
Apr 24, 2024, 3:58 PM EDT - Market closed
Northwest Biotherapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 2.13 | 6.97 | 15.17 | 9.98 | 0.37 | 22.22 | 0.12 | 6.19 | 21.81 | 13.39 | Upgrade
|
| Cash & Cash Equivalents | 2.13 | 6.97 | 15.17 | 9.98 | 0.37 | 22.22 | 0.12 | 6.19 | 21.81 | 13.39 | Upgrade
|
| Cash Growth | -69.48% | -54.08% | 51.95% | 2583.60% | -98.33% | 18894.87% | -98.11% | -71.64% | 62.91% | -27.62% | Upgrade
|
| Other Current Assets | 2 | 2.46 | 2.12 | 5.53 | 2.83 | 1.57 | 1.29 | 1.7 | 2.29 | 1.25 | Upgrade
|
| Total Current Assets | 4.13 | 9.43 | 17.29 | 15.51 | 3.2 | 23.8 | 1.4 | 7.88 | 24.1 | 14.64 | Upgrade
|
| Property, Plant & Equipment | 21.46 | 19.64 | 19.92 | 14.6 | 5.13 | 0.11 | 47.49 | 44.87 | 46.16 | 40 | Upgrade
|
| Long-Term Investments | 0.08 | 0.08 | 0.08 | 0.08 | 0.01 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Goodwill | 0.63 | 0.63 | 0.63 | 0.63 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Intangible Assets | 1.29 | 1.29 | 1.29 | 1.29 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Long-Term Assets | 0.36 | 0.27 | 0.96 | 0.79 | 0.79 | 0.76 | 0.02 | 0.15 | 0.54 | 3.8 | Upgrade
|
| Total Long-Term Assets | 23.82 | 21.9 | 22.87 | 17.39 | 5.93 | 0.87 | 47.51 | 45.02 | 46.7 | 43.8 | Upgrade
|
| Total Assets | 27.94 | 31.32 | 40.16 | 32.9 | 9.13 | 24.67 | 48.91 | 52.91 | 70.8 | 58.44 | Upgrade
|
| Accounts Payable | 13.79 | 17.64 | 10.95 | 12.74 | 7.19 | 20.09 | 18.4 | 35.73 | 17.18 | 15.56 | Upgrade
|
| Deferred Revenue | 0 | 0 | 0.25 | 0 | 0 | 4.8 | 6.2 | 7.64 | 7.98 | 7.41 | Upgrade
|
| Current Debt | 20.79 | 15.89 | 7.56 | 6.43 | 6.53 | 14.81 | 22.91 | 28.17 | 11.65 | 1.17 | Upgrade
|
| Other Current Liabilities | 10.62 | 92.47 | 115.02 | 363.25 | 27.47 | 30.13 | 40.17 | 4.86 | 27.98 | 44.74 | Upgrade
|
| Total Current Liabilities | 45.2 | 126.01 | 133.77 | 382.42 | 41.19 | 69.84 | 87.68 | 76.41 | 64.79 | 68.88 | Upgrade
|
| Long-Term Debt | 20.31 | 10.36 | 30.38 | 13.42 | 11.5 | 1.99 | 8.52 | 3 | 10.09 | 24.49 | Upgrade
|
| Other Long-Term Liabilities | 9.4 | 23.06 | 0 | 0 | 0 | 0 | 0 | 0 | 0.6 | 0.1 | Upgrade
|
| Total Long-Term Liabilities | 29.72 | 33.42 | 30.38 | 13.42 | 11.5 | 1.99 | 8.52 | 3 | 10.68 | 24.59 | Upgrade
|
| Total Liabilities | 74.92 | 159.43 | 164.15 | 395.85 | 52.7 | 71.83 | 96.2 | 79.41 | 75.47 | 93.47 | Upgrade
|
| Total Debt | 45.56 | 26.25 | 37.94 | 19.86 | 18.03 | 16.8 | 31.43 | 31.17 | 21.74 | 25.66 | Upgrade
|
| Debt Growth | 73.54% | -30.80% | 91.06% | 10.12% | 7.35% | -46.56% | 0.83% | 43.38% | -15.28% | 2000.00% | Upgrade
|
| Common Stock | 1.18 | 1.07 | 0.95 | 0.83 | 0.61 | 0.52 | 0.33 | 0.16 | 0.1 | 0.07 | Upgrade
|
| Retained Earnings | -1,359.72 | -1,297.12 | -1,192.09 | -1,371.22 | -839.91 | -824.41 | -788.62 | -715.48 | -635.26 | -520.52 | Upgrade
|
| Comprehensive Income | 1.54 | 3.15 | 0.36 | -1.15 | 0.84 | 1 | -0.6 | 1.85 | -0.12 | -0.19 | Upgrade
|
| Shareholders' Equity | -46.98 | -128.1 | -123.99 | -362.95 | -43.57 | -47.16 | -47.29 | -26.5 | -4.68 | -35.03 | Upgrade
|
| Total Liabilities and Equity | 27.94 | 31.32 | 40.16 | 32.9 | 9.13 | 24.67 | 48.91 | 52.91 | 70.8 | 58.44 | Upgrade
|
| Net Cash / Debt | -43.43 | -19.29 | -22.77 | -9.87 | -17.66 | 5.43 | -31.31 | -24.99 | 0.07 | -12.27 | Upgrade
|
| Net Cash Per Share | -0.04 | -0.02 | -0.02 | -0.01 | -0.03 | 0.01 | -0.13 | -0.22 | 0.00 | -0.21 | Upgrade
|
| Working Capital | -41.08 | -116.58 | -116.48 | -366.91 | -37.99 | -46.04 | -86.28 | -68.52 | -40.69 | -54.24 | Upgrade
|
| Book Value Per Share | -0.04 | -0.13 | -0.14 | -0.50 | -0.08 | -0.11 | -0.19 | -0.24 | -0.06 | -0.59 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.